CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Open-market sale Panzara Michael A. sold 10,603 shares at $2.31 ($24,493)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 970,025 shares (other)
- 4 Exercise or conversion Chief Financial Officer acquired 10,930 shares (option exercise)
- 4 Open-market sale Francis Chris sold 2,698 shares at $10.57 ($28,518)
- 4 Open-market sale President and CEO sold 11,205 shares at $10.57 ($118,437)
- 4 Open-market sale Panzara Michael A. sold 2,929 shares at $10.57 ($30,960)
- 4 Open-market sale Chief Technology Officer sold 3,145 shares at $10.57 ($33,243)
Page 7 of 14 · 274 filings